Compare LIXT & DXLG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | LIXT | DXLG |
|---|---|---|
| Founded | 2005 | 1976 |
| Country | United States | United States |
| Employees | 3 | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Clothing/Shoe/Accessory Stores |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 26.5M | 24.1M |
| IPO Year | N/A | 1994 |
| Metric | LIXT | DXLG |
|---|---|---|
| Price | $2.88 | $0.54 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $1.50 |
| AVG Volume (30 Days) | 41.6K | ★ 223.5K |
| Earning Date | 05-11-2026 | 03-19-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $435,017,000.00 |
| Revenue This Year | N/A | $3.85 |
| Revenue Next Year | N/A | $4.09 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $0.64 | $0.44 |
| 52 Week High | $6.09 | $1.69 |
| Indicator | LIXT | DXLG |
|---|---|---|
| Relative Strength Index (RSI) | 48.07 | 50.45 |
| Support Level | $2.50 | $0.49 |
| Resistance Level | $3.30 | $0.57 |
| Average True Range (ATR) | 0.24 | 0.08 |
| MACD | 0.03 | 0.01 |
| Stochastic Oscillator | 51.56 | 38.24 |
Lixte Biotechnology Holdings Inc is a biopharmaceutical company dedicated to improving patients' lives by developing a drug class called Protein Phosphatase 2A inhibitors. Its product pipeline is focused on inhibitors of protein phosphatase 2A, used in combination with cytotoxic agents and/or x-rays, immune checkpoint blockers, and other cancer therapies. The Company believes that inhibitors of protein phosphatases have therapeutic potential for a broad range of cancers. It focuses on the clinical development of a specific protein phosphatase inhibitor, referred to as LB-100, which has been shown to have clinical anti-cancer activity at doses that produce little or no toxicity.
Destination XL Group Inc is a retailer of branded and Tall men's clothing and shoes in the United States. It also sells products across the world. The company sells its products under the trade names Destination XL, DXL, DXL Men's Apparel, DXL outlets, Casual Male XL, and Casual Male XL outlets. The company has two principal operating segments: Store, and Direct business.